Opportunity Information: Apply for PA 09 121
Apply for PA 09 121
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research 93.399 Cancer Control.
- This funding opportunity was created on Mar 17, 2009 and posted on Mar 17, 2009.
- Applicants must submit their applications by May 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Independent school districts Special district governments County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21)" (Funding Opportunity Number PA-09-121) is a National Institutes of Health program sponsored by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI). Its central goal is to encourage exploratory and early-stage studies that improve understanding of how people make clinical and health-related decisions when they either have, or may be at risk for, illnesses that can become fatal relatively quickly if not addressed. The FOA frames "life threatening illness" broadly, including conditions that might be managed over many years with effective treatment (for example, HIV infection) as well as conditions that may be curable when detected and treated early (for example, early-stage breast cancer). The emphasis is not simply on medical outcomes, but on the real-world decision processes that shape whether individuals pursue prevention, screening, diagnostic evaluation, treatment, research participation, or end-of-life care.
A key feature of this opportunity is its focus on decision making across the entire trajectory of illness and risk, from the earliest point of considering preventive behaviors through advanced disease and end-of-life choices. The announcement highlights many kinds of decisions that can be studied, such as whether to join a preventive clinical trial (like an HIV vaccine study), whether to undergo genetic testing, how to choose between active treatment and "watchful waiting" approaches (as often discussed in early-stage prostate cancer), how to select among multiple treatment options, whether to participate in a therapeutic clinical trial, and how individuals and families make decisions about palliative care or other end-of-life preferences. Because these decisions frequently involve uncertainty, risk tradeoffs, changing values over time, and complicated information, the FOA is meant to stimulate research that clarifies how decisions are formed, what influences them, and how clinical communication and care systems can better support patients and those close to them.
This FOA uses the NIH Exploratory/Developmental Grant mechanism (R21), which is designed for early, innovative, and potentially high-impact projects that may still be at the hypothesis-building or pilot-testing stage. In other words, it supports research that can open new lines of inquiry, develop methods, generate preliminary data, or test promising approaches in a limited way before larger-scale studies. The R21 described here runs in parallel with a companion FOA of the same scientific scope that uses the R01 mechanism (PA-09-122), which is typically intended for more mature, fully developed research programs. Applicants should see the R21 as an opportunity to propose focused, well-justified exploratory work that can rapidly advance the science of clinical decision making in serious illness contexts.
Funding levels are presented with some flexibility because projects may vary widely in design, population, setting, and methods. The listing includes an award ceiling of $200,000, and it notes that the size, duration, and number of awards depend on the volume and quality of applications received, as well as the costs and timelines proposed. There is no cost sharing or matching requirement. The program is categorized under health and education-related federal assistance, with CFDA numbers 93.361 (Nursing Research) and 93.399 (Cancer Control), signaling relevance to both nursing science priorities and cancer control decision-making needs, while still being broadly applicable across life-threatening conditions.
Eligibility is intentionally broad and includes many organization types that might be positioned to study decision making in clinical, community, and health systems contexts. Eligible applicants include public and private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (other than small businesses) as well as small businesses, state and local governments (including counties, cities, townships, special districts, and independent school districts), public housing authorities and Indian housing authorities, federally recognized tribal governments and other tribal organizations, and U.S. territories or possessions. The FOA also explicitly recognizes additional eligible entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based and community-based organizations, regional organizations, eligible federal agencies, and even non-U.S. entities (foreign organizations). This breadth reflects the reality that decision making around life-threatening illness occurs in many settings and populations, and that strong research teams may emerge from academic medical centers, community organizations, or cross-sector partnerships.
In terms of administrative details, the opportunity was posted on March 17, 2009, with a closing date of May 7, 2012, and it was archived on June 7, 2012. While the program itself is historical in the form provided, the underlying topic area remains a core NIH interest, and the FOA points users to the official NIH grants page for the complete announcement and to NIH Office of Extramural Research support contacts for access or technical issues.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21)" and the Funding Opportunity Number is PA-09-121.
Which agencies sponsor this funding opportunity?
This NIH program is sponsored by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI).
What is the central goal of this FOA?
The goal is to encourage exploratory and early-stage research that improves understanding of how people make clinical and health-related decisions when they have, or may be at risk for, illnesses that can become fatal relatively quickly if not addressed.
What does the FOA mean by "life threatening illness"?
The FOA defines life threatening illness broadly. It includes conditions that may be managed over many years with effective treatment (for example, HIV infection) and conditions that may be curable when detected and treated early (for example, early-stage breast cancer).
Is the focus only on medical outcomes?
No. The FOA emphasizes real-world decision processes that influence whether individuals pursue prevention, screening, diagnostic evaluation, treatment, research participation, or end-of-life care, rather than focusing only on medical outcomes.
What stages of illness or risk does this FOA cover?
The FOA is designed to support research on decision making across the full trajectory, from early consideration of preventive behaviors through advanced disease and end-of-life choices.
What kinds of decisions are examples of what can be studied under this FOA?
Examples highlighted in the announcement include decisions about joining a preventive clinical trial (such as an HIV vaccine study), undergoing genetic testing, choosing between active treatment and "watchful waiting" (as often discussed in early-stage prostate cancer), selecting among multiple treatment options, participating in a therapeutic clinical trial, and making choices about palliative care or other end-of-life preferences.
Why is decision making in these contexts a research priority under this FOA?
The FOA notes that these decisions often involve uncertainty, risk tradeoffs, changing values over time, and complicated information. It aims to stimulate research that clarifies how decisions are formed, what influences them, and how clinical communication and care systems can better support patients and those close to them.
What grant mechanism does this FOA use?
This FOA uses the NIH Exploratory/Developmental Grant mechanism (R21).
What does an R21 mechanism imply about the type of projects NIH is seeking here?
The R21 is intended for early, innovative, and potentially high-impact projects that may still be in hypothesis-building or pilot-testing stages. The FOA positions it as support for work that can open new lines of inquiry, develop methods, generate preliminary data, or test promising approaches in a limited way before larger-scale studies.
Is there a related FOA using a different mechanism?
Yes. The R21 FOA (PA-09-121) runs in parallel with a companion FOA of the same scientific scope using the R01 mechanism (PA-09-122), which is typically aimed at more mature, fully developed research programs.
How much funding is available per award?
The listing includes an award ceiling of $200,000. It also notes that project size, duration, and the number of awards depend on the volume and quality of applications received and on the costs and timelines proposed.
Is cost sharing or matching required?
No. The FOA states that there is no cost sharing or matching requirement.
What CFDA numbers are associated with this opportunity?
The opportunity is categorized under health and education-related federal assistance with CFDA numbers 93.361 (Nursing Research) and 93.399 (Cancer Control).
Does the focus extend beyond cancer?
Yes. While the FOA includes cancer-related examples and includes a cancer control CFDA number, it frames "life threatening illness" broadly and is described as applicable across serious conditions where decision making is critical.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits with and without 501(c)(3) status; for-profit organizations (including small businesses); state and local governments (including counties, cities, townships, special districts, and independent school districts); public housing authorities and Indian housing authorities; federally recognized tribal governments and other tribal organizations; and U.S. territories or possessions.
Are specific types of institutions explicitly recognized as eligible?
Yes. The FOA explicitly recognizes eligibility for entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based and community-based organizations, regional organizations, eligible federal agencies, and non-U.S. entities (foreign organizations).
Are foreign organizations eligible to apply?
Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) among eligible applicants.
When was this opportunity posted, and what were the closing and archive dates?
The opportunity was posted on March 17, 2009. The closing date was May 7, 2012, and it was archived on June 7, 2012.
Is this FOA currently active?
No. Based on the provided dates, this specific FOA is historical: it has a past closing date and is listed as archived.
Where does the FOA direct applicants for the complete official announcement and help?
It points users to the official NIH grants page for the complete announcement and to NIH Office of Extramural Research support contacts for access or technical issues.
What is the overarching research theme emphasized across proposed studies?
The FOA emphasizes understanding how decisions are made, what factors influence those decisions, and how clinical communication and care systems can better support patients and those close to them as decisions evolve across prevention, diagnosis, treatment, research participation, and end-of-life care.
Browse more opportunities from the same category: Education Health
Next opportunity: Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21)
Previous opportunity: Mental Health Dissertation Research Grant to Increase Diversity (R36)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 121
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 121) also looked into and applied for these:
| Funding Opportunity |
|---|
| Biomedical Research on the International Space Station (BioMed ISS) (UH2/UH3) Apply for PAR 09 120 Funding Number: PAR 09 120 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Building System Capacity for Implementing Evidence Based Practices in Substance Abuse Treatment and Prevention (R34) Apply for PA 09 105 Funding Number: PA 09 105 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R03) Apply for PA 09 143 Funding Number: PA 09 143 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R21) Apply for PA 09 144 Funding Number: PA 09 144 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Cancer Surveillance Using Health Claims based Data System (R01) Apply for PA 09 145 Funding Number: PA 09 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials (R34) Apply for PA 09 146 Funding Number: PA 09 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Economic Studies of Health Insurance Coverage on Drug Abuse Treatment Availability, Access, Costs, and Quality (R01) Apply for RFA DA 10 004 Funding Number: RFA DA 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Studies of Energy Balance and Cancer in Humans (R01) Apply for PA 09 148 Funding Number: PA 09 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Studies of Energy Balance and Cancer in Humans (R21) Apply for PA 09 149 Funding Number: PA 09 149 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 09 147 Funding Number: PAR 09 147 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Apply for PAR 09 157 Funding Number: PAR 09 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,250,000 |
| NLM Applied Informatics Grants (G08) Apply for RFA LM 09 001 Funding Number: RFA LM 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Developmental Research in Cancer Prognosis and Prediction (R21) Apply for PA 09 158 Funding Number: PA 09 158 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developmental Research in Cancer Prognosis and Prediction (R33) Apply for PA 09 159 Funding Number: PA 09 159 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 09 160 Funding Number: PAR 09 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 09 161 Funding Number: PAR 09 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R21) Apply for PA 09 167 Funding Number: PA 09 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R03) Apply for PA 09 168 Funding Number: PA 09 168 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program (U10) Apply for RFA CA 09 023 Funding Number: RFA CA 09 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Renewal of Centers of Biomedical Research Excellence (COBRE)P20 Apply for PAR 09 180 Funding Number: PAR 09 180 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 121", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
